Abour CALYM

The CALYM Carnot institute is an academic research consortium that offers a unique R&D approach in lymphoma treatment and diagnosis spanning from new target identification to large international Phase III clinical trials and beyond.

CALYM brings together 15 entities with complementary expertise in preclinical, translational and clinical lymphoma research: the Lymphoma Study Association (LYSA), a cooperative group, international leader of lymphoma research with 500 members within 120 centers in 4 countries, the Lymphoma Academic Research Organisation (LYSARC), a fully integrated academic clinical organisation - the largest in Europe in this field – and 13 public preclinical research teams of excellence in lymphoma based at universities and hospitals across France.

This set without international equivalent, aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase and offers various terms of collaboration covering all stages of R&D.

More information at www.calym.org